Core DNA: Coreweave and Nebius Couldn’t Be More Different and Why It Matters
CoreWeave and Nebius both court the same hyperscaler clients with NVIDIA hardware at their core, yet their financial blueprints point toward completely opposite fates if GPU pricing shifts or interest rates bite.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
CoreWeave (NASDAQ: CRWV) and Nebius Group (NASDAQ: NBIS | NBIS Price Prediction) just delivered Q1 2026 results that look similar on the surface: both are NVIDIA-backed AI cloud providers chasing hyperscaler contracts. Underneath, the businesses are built on completely different foundations. CoreWeave is a leveraged infrastructure developer. Nebius is an AI-native software cloud platform. That distinction shaped everything about their quarters.
Bookings Machine Meets Software Stack
CoreWeave printed $2.08 billion in revenue, up 111.69% year over year, alongside a $99.4 billion revenue backlog anchored by a $21 billion Meta commitment and a fresh Anthropic deal for Claude. CEO Michael Intrator framed the pitch clearly: “We sit between the models and the silicon.” That is the whole thesis. Rent GPUs at scale, wrap them in Weights & Biases tooling, collect long-dated bookings.
Nebius told a different story. Revenue landed at $399 million, missing the $593 million consensus, but Nebius AI Cloud alone grew 841% year over year at a 45% adjusted EBITDA margin. Arkady Volozh is building a full software layer, including Aether 3.5 serverless AI, Token Factory managed inference, and stakes in ClickHouse, Toloka, and Avride autonomous delivery. The company also secured its own $27 billion five-year Meta agreement.
Debt-Fueled Scale vs. Cash-Rich Optionality
The balance sheets reveal the real divergence. CoreWeave carries $50.81 billion in total liabilities against $2.24 billion in cash, with interest expense doubling to $536 million and Q1 capex hitting $7.7 billion. That is the leveraged developer model working in overdrive. Nebius sits on $9.30 billion of cash, having raised $6.3 billion from financing activities, and it actually issued explicit 2026 guidance of $3.0 billion to $3.4 billion in revenue with a ~40% adjusted EBITDA margin. CoreWeave declined to give formal guidance.
| Lens | CoreWeave | Nebius |
| Core DNA | Leveraged infra developer | AI-native software platform |
| Backlog / RPO | $99.4B | $33.6B |
| Cash Position | $2.24B | $9.30B |
| Key Vulnerability | Interest expense, capex | Revenue miss, execution |
Inference Ramp Will Settle This
Both companies achieved NVIDIA Exemplar Cloud status, but on different systems: GB200 NVL72 for CoreWeave and GB300 NVL72 for Nebius. I will be watching whether CoreWeave’s Dedicated Inference product converts that $99B backlog into cash before debt service compresses margins. For Nebius, the question is whether Token Factory, plus the Tavily, Eigen AI, and Clarifai acquisitions, can push ARR toward the $7 billion to $9 billion year-end target.
What the Setup Signals Right Now
CoreWeave offers the largest hyperscaler bookings pipeline paired with a highly leveraged build-out, though shares are down 28.67% since the May 7 report. On the metrics, Nebius screens as the more defensive profile. The 45% segment EBITDA margin, cleaner balance sheet, and diversified software stack look more defensible if GPU pricing softens. That said, the 316.73% one-year run leaves little room for the next quarter to disappoint.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
